Vaccination

US funding sees Covid-19 antibody trial enter next phase

UK pharmaceuticals group AstraZeneca said on Monday it will advance trials of a Covid-19 treatment to a crucial third stage, after the United States invested $486 million (411 million euros) in its development.

Other

Canadian cannabis firms agree to merge to create pot giant

Canadian cannabis grower and seller Aurora Cannabis announced Wednesday a friendly acquisition of CanniMed Therapeutics in a deal valued at an estimated Can$1.1 billion (US$890 million) to create a global pot behemoth.

Medications

US health watchdog curbs exports from India's Wockhardt

The US health regulator has restricted exports from a plant owned by Indian generic drugmaker Wockhardt in the latest ban on its products, sending the company's shares tumbling 14 percent on Wednesday.

page 3 from 4